Provided herein are specific doses of, and dosing regimens for, using a HIF prolyl hydroxylase inhibitor in treating or preventing anemia, such as anemia secondary to or associated with chronic kidney disease, anemia associated with or resulting from chemotherapy, or anemia associated with AIDS.本發明提供使用HIF脯胺醯基羥化酶抑制劑治療或預防貧血之特定劑量及給藥方案,該貧血為諸如慢性腎病繼發或關聯之貧血、化學療法關聯或引起之貧血或與AIDS關聯之貧血。